|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
|
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Current assets | |||||||
| Cash and cash equivalents | |||||||
| Marketable securities | |||||||
| Trade and other receivables | |||||||
| Inventories | |||||||
| Derivative assets | |||||||
| Prepaid expenses | |||||||
| Other current assets | |||||||
| Assets held for sale | |||||||
| Current assets | |||||||
| Non-current assets | |||||||
| Restricted cash | |||||||
| Inventories | |||||||
| Mineral properties, plant and equipment | |||||||
| Investments in associates | |||||||
| Deferred income tax assets | |||||||
| Other assets | |||||||
| Total assets | |||||||
| Liabilities and Equity | |||||||
| Current liabilities | |||||||
| Accounts payable and accrued liabilities | |||||||
| Income taxes payable | |||||||
| Current portion of loans and borrowings | |||||||
| Current portion of deferred revenue | |||||||
| Current portion of derivative liabilities | |||||||
| Other current liabilities | |||||||
| Liabilities relating to assets held for sale | |||||||
| Current liabilities | |||||||
| Non-current liabilities | |||||||
| Loans and borrowings | |||||||
| Deferred revenue | |||||||
| Derivative liabilities | |||||||
| Reclamation and closure cost provisions | |||||||
| Deferred income tax liabilities | |||||||
| Other non-current liabilities | |||||||
| Total liabilities | |||||||
| Shareholders’ equity | |||||||
| Common shares | |||||||
| Reserves | |||||||
| Accumulated other comprehensive income (loss) | |||||||
| Retained earnings | |||||||
| Equity attributable to Equinox Gold shareholders | |||||||
| Total equity | |||||||
| Total liabilities and equity | |||||||
Loading...